RBFC
EMN icon

Roman Butler Fullerton & Co’s Eastman Chemical EMN Stock Holding History

Roman Butler Fullerton & Co’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,864
Closed -$223K – 252
2025
Q1 		$223K Buy
2,864
+164
+6% +$15.5K 0.09% 198
2024
Q4 		$252K Buy
2,700
+428
+19% +$43.9K 0.08% 200
2024
Q3 		$251K Buy
+2,272
New +$227K 0.08% 218

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Roman Butler Fullerton & Co's EMN Position: Q2 2025 in Review

Roman Butler Fullerton & Co sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 2,864 shares — an estimated $223K sold.

Roman Butler Fullerton & Co first reported a position in EMN in Q3 2024 and held it in 3 quarters. The position peaked at $252K in Q4 2024. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

  • Roman Butler Fullerton & Co reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 2,864 Eastman Chemical shares in Q2 2025, an estimated $223K.
  • Roman Butler Fullerton & Co first reported a position in Eastman Chemical in Q3 2024 and held it in 3 quarters.
  • Roman Butler Fullerton & Co's Eastman Chemical position peaked at $252K in Q4 2024.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2025, filed 30 Jul 2025.